Williams & Connolly LLP represents a high-profile client base in the full spectrum of commercial disputes, from breach of contract and fiduciary duty actions to fraud and tortious interference claims to licensing, employment and real estate and construction disputes. It has a strong background in internal corporate governance disputes and investigations. The Washington DC-based practice successfully represents both individuals and corporations, at both a federal and state level and in consumer class actions. Dane Butswinkas’ broad industry expertise sees him represent pharma companies in product liability and medical malpractice cases, as well as clients across the financial services, food, telecoms, tech and power sectors. Robert Van Kirk co-leads the securities litigation and enforcement teams, active in litigation, investigations, and arbitration in various jurisdictions. He is also co-chair of the firm’s commercial litigation team, alongside Edward Bennett, who handles commercial, corporate governance, antitrust and trade practices, and boasts expertise in the banking and financial services and IP sectors. Bryan Wilson is co-chair of the firm’s unfair competition, trade secrets and restrictive covenants team, with an active plaintiff and defendant practice.
Legal 500 Editorial commentary
Profile

Key clients

  • Platinum Equity Advisors, LLC
  • United Therapeutics Corp.
  • The Carlyle Group, Inc., and Certain Subsidiaries, Officers, and Directors
  • Google
  • Amazon
  • Coventry Capital LLC
  • W.W. Grainger, Inc.
  • The University of Notre Dame
  • The Carlyle Group, Inc., various affiliated entities, and the former directors of Authentix, Inc.
  • Bank of America

Work highlights

  • Representing Platinum Equity Advisors in connection with multiple lawsuits against a portfolio company, Incora, which were filed in state court challenging a controversial financing transaction in the aftermath of the pandemic.
  • Representing United Therapeutics Corp. in a breach of contract case tried in early 2024 related to UTC’s drug Remodulin, a treatment for patients with the rare disease pulmonary arterial hypertension.
  • Representing The Carlyle Group, Inc. and various affiliated entities, along with former directors of Authentix, Inc., in a case brought by minority shareholders alleging breaches of the stockholder agreement, including breaches of fiduciary duty and other claims related to the 2017 sale of Authentix.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Dane Butswinkas; Robert Van Kirk; Edward Bennett

Other key lawyers

Bryan Wilson; Adrienne Van Winkle; Steven Cady; Sarah Kirkpatrick